# Ivabradine for Long-Term Effects of COVID-19 With POTS Cohort

> **NCT05481177** · PHASE4 · UNKNOWN · sponsor: **Uniformed Services University of the Health Sciences** · enrollment: 250 (estimated)

## Conditions studied

- Long Haul COVID
- Postural Orthostatic Tachycardia Syndrome

## Interventions

- **DRUG:** Ivabradine

## Key facts

- **NCT ID:** NCT05481177
- **Lead sponsor:** Uniformed Services University of the Health Sciences
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-06-14
- **Primary completion:** 2024-09-01
- **Final completion:** 2024-09-01
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2023-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05481177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05481177, "Ivabradine for Long-Term Effects of COVID-19 With POTS Cohort". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT05481177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*